期刊文献+

大脑胶质瘤病临床分析(附17例报告) 被引量:3

Clinical Analysis of Gliomatosis Cerebri
下载PDF
导出
摘要 目的:探讨大脑胶质瘤病(gliomatosis cerebri,GC)的临床特征、诊断和治疗方法,提高该病的诊断和治疗水平。方法:对北京市海军总医院1989年1月至2007年10月和吉林大学中日联谊医院2005年1月至2007年12月收治的17例GC患者进行回顾性分析,结合国内外文献分析讨论。结果:17例GC患者临床表现复杂多样,主要表现为T1精WI神呈障低碍信和号性或格等改信变号、改头变痛,、T癫2W痫I呈发广作泛和高偏信瘫号。,影信像号学较检均查匀示,无病或变轻范微围强广化泛。,2C例T呈行稍MR低S密检度查或均低显等示混胆杂碱(密C度ho),上升、胆碱/肌酸(Cho/Cr)和胆碱/N-乙酰天门冬氨酸(Cho/NAA)比值升高。病理学检查示肿瘤细胞广泛浸润大脑半球灰白质,主要沿血管及神经轴突周围呈浸润性生长。17例GC患者中,星形细胞瘤Ⅰ级3例,Ⅱ级8例,Ⅱ~Ⅲ级2例,Ⅲ级4例。总体中位生存期为9个月(21天~24个月)。结论:当患者出现神经系统症状,影像学检查显示弥漫性病灶累及两个以上脑叶,MRI呈长T1、长T2异常信号,增强扫描无强化或轻微强化,MRS示Cho/Cr和Cho/NAA比值升高时,应考虑GC的诊断。最终确诊需行组织病理学检查;立体定向活检术由于其微创、安全、可靠的特点,在大脑胶质瘤病诊断中具有重要的应用价值。GC不适合手术治疗,放疗、化疗及125I籽粒植入间质内放疗对GC有一定的抑制作用,但整体中位生存期短,预后差。 Objective: To investigate the clinical features and methods used to diagnose and treat gliomatosis cerebri (GC). Methods: Seventeen patients with GC that were diagnosed and treated in Navy General Hospital of PLA from January 1989 to October 2007 and in China-Janpan Union Hospital from January 2005 to December 2007 were retrospectively analyzed. Results: The clinical manifestations of these 17 patients were variable. The main clinical manifestations included headache, mental status changes, seizure and hemiparalysis. Radiological examination revealed diffuse lesions that produced hypodense signal on CT, a hypo- or isoin-tense signal on T1WI, and a scattered diffuse hyperintense signal on T2WI. Contrast enhancement was absent or minimal. MRS revealed increased choline (Cho)/creatine (Cr) and choline (Cho)/N-acetylaspartate (NAA) ratios in tumors compared with normal brain tissues. Histological examination revealed the widespread infiltration of neoplastic glial cells with minimal destruction of pre-existing structures. All cases were astrocytomas including 3 cases of grade Ⅰ, 8 cases of grade Ⅱ, 2 cases of grade Ⅱ - Ⅲ, and 4 cases of grade Ⅲ. The median survival was 9 months (ranged from 21 days to 24 months). Conclusion: When patients have symptoms and neuroimaging provides MRI evidence of a diffuse infiltrative process involving more than two cerebral lobes that extends to infratentorial structures, a diagnosis of GC should be considered. Stereotactic biopsy is a powerful and safe method to diagnose GC. Surgery is not a suitable option for GC. Radiotherapy, chemotherapy and ^125I seed brachytherapy seem to be helpful, but the median survival is short and the prognosis is still poor.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第14期781-784,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30672159) 教育部新世纪优秀人才支持计划基金资助(编号:NCET-06-0306)~~
关键词 大脑胶质瘤病 活体组织检查 病理学 诊断 治疗 Gliomatosis cerebri Stereotaxic techniques Pathology Diagnosis Treatment
  • 相关文献

参考文献16

  • 1Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO dassificadon of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114(2) : 97-109.
  • 2田宇,艾天贻,赵兴利,李东源.立体定向手术中确定三维长轴和入颅点的方法——“四点一线手算法”[J].立体定向和功能性神经外科杂志,2007,20(1):48-49. 被引量:10
  • 3Kim DG, Yang HJ, Park I.A, et al. Gliomatosis cerebri: clinical features, treatment, and prognosis[J]. Acta Neurochir, 1998, 140 (8): 755-762.
  • 4Mawrin C, Kirches E, Schneider-Stock R, et al. Analysis of TP53 and PTEN in gliomatosis cerebri[J]. Acta Neuropathol, 2003, 105(6): 529-536.
  • 5Herrlinger U, Felsberg J, Kuker W, et al. Gliomatosis cerebri: molecular pathology and clinical course[J]. Ann Neurol, 2002, 52 (4): 390-399.
  • 6Mawrin C, Kirches E, Schneider-Stock R, et al. Alterations of cell cycle regulators in gliomatosis cerebri[J]. J Neurooncol, 2005, 72(2): 115-122.
  • 7Kros JM, Zheng P, Dinjens WN, et al. Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis[J]. J Neuropathol Exp Neurol, 2002, 61(9): 806-814.
  • 8Mawrin C. Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease[J]? Acta Neuropathol, 2005, 110(6): 527-536.
  • 9Mawrin C, Schneider T, Firsching R, et al. Assessment of tumor cell invasion factors in gliomatosis cerebri[J]. J Neurooncol, 2005, 7B(2): 109-115.
  • 10Taillibert S, Chodkiewicz C, Laigle-Donadey F, et al. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature[J].J Neurooncol, 2006, 76(2): 201-205.

二级参考文献8

  • 1Timiryasova TM,Chen B,Haghighat P,et al:Vaccinia virusmediayed expression of wild-type P53 suppresses glioma cell growth and induces apoptosis [J].Int J Oncol,1999,14(5):845-854.
  • 2Lang FF,Yung WK,Raju U,et al.Enhancement of radiosensitivity of wild-type P53 human glioma cells by adenovirus-mediated delivery of the P53 gene[J].J Neurosurg,1998.89(1):125-132.
  • 3Asai A.Miyagi Y.Hashimoto H,et al.Negative effects of wildtype P53 and s-Myc on cellular growth and tumorigenicity of glioma cells.Implication of the tumor suppressor genes for gene therapy [J].J Neurooncol.1994.19(3):259-268.
  • 4Groothuis DR.Wright DC.Ostertag CB,et al.The effect of ^125I interstitial radiotherapy on blood-brain barrier function in normal canine brain[J].J Neurosurg/1987.67(6):895-902.
  • 5Larson DA,Suplica JM,Chang SM,et al.Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme[J].Neuro Oncol,2004,6(2):119-126.
  • 6Zamorano L,Li Q,Tekyi-Mensah S,et al.Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas [J].Stereotact Funct Neurosurg,2003,81(1-4):10-17.
  • 7McDermott MW,Sneed PK,Gutin PH,et al.Interstitial brachytherapy for malignant brain tumors [J].Semin Surg Oncol.1998,14(1):79-87.
  • 8Nath R,Anderson LL,Luxtion G,et al:Dosimetry of interstitial brachytherapy soutces:recommendations of the AAPM radiation therapy committee task group No.43.American Association of Physicistsin Medcine[J].Med Phys.1995.22(2):209-234.

共引文献10

同被引文献43

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部